Abstract
In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Current Drug Therapy
Title: In Situ Gels Based Drug Delivery Systems
Volume: 6 Issue: 3
Author(s): Madhugiri P. Venkatesh, Purohit K. Liladhar, Teggin M.P. Kumar and Hosakote G. Shivakumar
Affiliation:
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Abstract: In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Export Options
About this article
Cite this article as:
P. Venkatesh Madhugiri, K. Liladhar Purohit, M.P. Kumar Teggin and G. Shivakumar Hosakote, In Situ Gels Based Drug Delivery Systems, Current Drug Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157488511796392004
DOI https://dx.doi.org/10.2174/157488511796392004 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol
Current Drug Delivery Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Recent Advances in Intraocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Current Pharmaceutical Design Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
Current Drug Targets Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Current Drug Targets Antineovascular Agents in the Treatment of Eye Diseases
Current Pharmaceutical Design Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets ANN Classification and Modified Otsu Labeling on Retinal Blood Vessels
Current Signal Transduction Therapy Intraocular Delivery of Anti-Infective Drugs-Bacterial, Viral, Fungal and Parasitic
Recent Patents on Anti-Infective Drug Discovery Update on the Therapy of Behçets Disease
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Anti-VEGF Molecules for the Management of Diabetic Macular Edema
Current Pharmaceutical Design Erythropoietin in Stroke Therapy: Friend or Foe
Current Medicinal Chemistry Prospectives for Gene Therapy of Retinal Degenerations
Current Genomics Histidine Rich Glycoprotein, an Endogenous Regulator of Macrophage and Endothelial Biology
Current Angiogenesis (Discontinued) The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Redox mechanisms in pathological angiogenesis in the retina: roles for NADPH oxidase
Current Pharmaceutical Design Drug Delivery to the Posterior Segment of the Eye: Challenges and Opportunities
Drug Delivery Letters